200 related articles for article (PubMed ID: 29290109)
1. Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
Das SK; Ghosh A; Paul Chowdhuri S; Halder N; Rehman I; Sengupta S; Sahoo KC; Rath H; Das BB
J Med Chem; 2018 Feb; 61(3):804-817. PubMed ID: 29290109
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.
Kundu B; Das SK; Paul Chowdhuri S; Pal S; Sarkar D; Ghosh A; Mukherjee A; Bhattacharya D; Das BB; Talukdar A
J Med Chem; 2019 Apr; 62(7):3428-3446. PubMed ID: 30897325
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.
Yu LM; Zhang XR; Li XB; Yang Y; Wei HY; He XX; Gu LQ; Huang ZS; Pommier Y; An LK
Eur J Med Chem; 2015 Aug; 101():525-33. PubMed ID: 26188908
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II and tubulin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexes.
Sordet O; Goldman A; Pommier Y
Mol Cancer Ther; 2006 Dec; 5(12):3139-44. PubMed ID: 17172417
[TBL] [Abstract][Full Text] [Related]
5. Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.
Drwal MN; Agama K; Wakelin LP; Pommier Y; Griffith R
PLoS One; 2011; 6(9):e25150. PubMed ID: 21966440
[TBL] [Abstract][Full Text] [Related]
6. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.
Montaudon D; Palle K; Rivory LP; Robert J; Douat-Casassus C; Quideau S; Bjornsti MA; Pourquier P
J Biol Chem; 2007 May; 282(19):14403-12. PubMed ID: 17355975
[TBL] [Abstract][Full Text] [Related]
8. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.
Regairaz M; Zhang YW; Fu H; Agama KK; Tata N; Agrawal S; Aladjem MI; Pommier Y
J Cell Biol; 2011 Nov; 195(5):739-49. PubMed ID: 22123861
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
Majumdar P; Bathula C; Basu SM; Das SK; Agarwal R; Hati S; Singh A; Sen S; Das BB
Eur J Med Chem; 2015 Sep; 102():540-51. PubMed ID: 26312433
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.
Das SK; Rehman I; Ghosh A; Sengupta S; Majumdar P; Jana B; Das BB
Nucleic Acids Res; 2016 Sep; 44(17):8363-75. PubMed ID: 27466387
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals.
Sordet O; Khan QA; Plo I; Pourquier P; Urasaki Y; Yoshida A; Antony S; Kohlhagen G; Solary E; Saparbaev M; Laval J; Pommier Y
J Biol Chem; 2004 Nov; 279(48):50499-504. PubMed ID: 15448130
[TBL] [Abstract][Full Text] [Related]
13. Highly Purified Top1-Bound DNA Fragments.
Marinello J; Capranico G
Methods Mol Biol; 2022; 2528():203-213. PubMed ID: 35704193
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors.
Jing CB; Fu C; Prutsch N; Wang M; He S; Look AT
Leukemia; 2020 Nov; 34(11):2992-3006. PubMed ID: 32572188
[TBL] [Abstract][Full Text] [Related]
15. Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.
Seol Y; Zhang H; Agama K; Lorence N; Pommier Y; Neuman KC
Mol Cancer Ther; 2015 Nov; 14(11):2552-9. PubMed ID: 26351326
[TBL] [Abstract][Full Text] [Related]
16. 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.
Kiselev E; DeGuire S; Morrell A; Agama K; Dexheimer TS; Pommier Y; Cushman M
J Med Chem; 2011 Sep; 54(17):6106-16. PubMed ID: 21823606
[TBL] [Abstract][Full Text] [Related]
17. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
[TBL] [Abstract][Full Text] [Related]
18. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
Tanizawa A; Kohn KW; Kohlhagen G; Leteurtre F; Pommier Y
Biochemistry; 1995 May; 34(21):7200-6. PubMed ID: 7766631
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission.
Sordet O; Goldman A; Redon C; Solier S; Rao VA; Pommier Y
J Biol Chem; 2008 Aug; 283(34):23200-8. PubMed ID: 18556653
[TBL] [Abstract][Full Text] [Related]
20. Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.
Sooryakumar D; Dexheimer TS; Teicher BA; Pommier Y
Mol Cancer Ther; 2011 Aug; 10(8):1490-9. PubMed ID: 21636699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
